Inge M. De Jong
Valby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction to: Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.
Journal: Psychopharmacology
Published: October 26, 2019
Impaired Kv7 channel function in cerebral arteries of a tauopathy mouse model (rTg4510).
Journal: Physiological reports
Published: August 06, 2018
Altered dopaminergic firing pattern and novelty response underlie ADHD-like behavior of SorCS2-deficient mice.
Journal: Translational psychiatry
Published: July 13, 2018
Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.
Journal: Psychopharmacology
Published: June 13, 2018
The Serotonin Receptor 6 Antagonist Idalopirdine and Acetylcholinesterase Inhibitor Donepezil Have Synergistic Effects on Brain Activity-A Functional MRI Study in the Awake Rat.
Journal: Frontiers in pharmacology
Published: February 20, 2017
Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease.
Journal: Neuropharmacology
Published: January 19, 2017
Effects of the 5-HT6 receptor antagonist idalopirdine on extracellular levels of monoamines, glutamate and acetylcholine in the rat medial prefrontal cortex.
Journal: European journal of pharmacology
Published: October 13, 2016
Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT6 receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements.
Journal: The European journal of neuroscience
Published: May 27, 2016
The 5-HT6 receptor antagonist idalopirdine potentiates the effects of donepezil on gamma oscillations in the frontal cortex of anesthetized and awake rats without affecting sleep-wake architecture.
Journal: Neuropharmacology
Published: April 28, 2016
The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus.
Journal: Neuropharmacology
Published: November 13, 2015
Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.
Journal: Journal of Alzheimer's disease : JAD
Published: November 01, 2015
The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin.
Journal: Bioorganic & medicinal chemistry letters
Published: October 16, 2013
Last Updated: 09/26/2026